Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al
- PMID: 32471900
- DOI: 10.1136/annrheumdis-2020-217875
Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al
Keywords: hydroxychloroquine; immune system diseases; lupus erythematosus, systemic; therapeutics.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24. Ann Rheum Dis. 2020. PMID: 32332072 No abstract available.
-
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'.Ann Rheum Dis. 2021 Mar;80(3):e33. doi: 10.1136/annrheumdis-2020-217827. Epub 2020 May 29. Ann Rheum Dis. 2021. PMID: 32471898 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical